US 10928391
CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
granted A61KA61K39/3955A61K47/6807
Quick answer
US patent 10928391 (CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K39/3955, A61K47/6807